Showing results (31-40 of 176) with videos related to
Sort By:
Pageof 18
Kardiologia Polska|June 17, 2011
Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary interventionWiktor Kuliczkowski, Małgorzata Greif, Mariusz Gąsior, et al.Journal of Diabetes and Its Complications|May 4, 2016
Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarctionBartosz Hudzik, Janusz Szkodziński, Andrzej Lekston, et al.Kardiologia Polska|August 19, 2007
Haemorheological factors and myocardial reperfusion in patients with ST-elevation myocardial infarction undergoing primary coronary interventionJarosław Wasilewski, Bolesław Turczyński, Ludmiła Słowińska, et al.Kardiologia Polska|June 10, 2008
[Dual antiplatelet drug resistance in a patient allergic to clopidogrel: a case report]Wiktor Kuliczkowski, Jacek Sikora, Krzysztof Dyrbuś, et al.Przeglad Lekarski|December 13, 2005
[Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy]Bozena Szyguła-Jurkiewicz, Romuald Wojnicz, Przemysław Trzeciak, et al.Archives of Medical Science : AMS|July 13, 2013
Higher mortality in women after ST-segment elevation myocardial infarction in very young patientsMarcin Sadowski, Agnieszka Janion-Sadowska, Mariusz Gąsior, et al.Journal of Cachexia, Sarcopenia and Muscle|August 10, 2019
Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetesJacek T Niedziela, Bartosz Hudzik, Krzysztof Strojek, et al.Disease Markers|August 17, 2017
The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary InterventionTadeusz Osadnik, Andrzej Lekston, Kamil Bujak, et al.Przeglad Lekarski|August 13, 2005
[Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension]Jan Wodniecki, Wojciech Jacheć, Lech Poloński, et al.Polskie Archiwum Medycyny Wewnetrznej|September 1, 2005
[12-month outcomes of percutaneous and surgical revascularization in acute coronary syndromes without ST-segment elevation in patients with multivessel coronary artery disease]Bozena Szyguła-Jurkewicz, Krzysztof Wilczek, Agnieszka Gorzkowska, et al.Pageof 18